Patent details

Basic Information

Publication number:

EP2482848

PCT Application Number:

US2010050759

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP108211889

PCT Publication Number:

WO2011041441

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ENDOGLIN ANTIBODIES

French Title of Invention:

ANTICORPS ANTI-ENDOGLINE

German Title of Invention:

ENDOGLIN-ANTIKÖRPER

SPC Number:

Dates

Filing date:

29/09/2010

Grant date:

15/01/2020

EP Publication Date:

08/08/2012

PCT Publication Date:

07/04/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/01/2020

EP B1 Publication Date:

15/01/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/09/2020

Expiration date:

29/09/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/01/2020

 

 

Name:

Tracon Pharmaceuticals, Inc.

Address:

4350 La Jolla Village Drive Suite 800, San Diego, CA 92122, United States (US)

Inventor

1

Name:

VASQUEZ, Maximiliano

Address:

United States (US)

2

Name:

THEUER, Charles

Address:

United States (US)

Priority

1

Priority Number:

247290 P

Priority Date:

30/09/2009

Priority Country:

United States (US)

2

Priority Number:

751907

Priority Date:

31/03/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/282; A61K 31/337; A61K 31/4045; A61K 31/44; A61K 31/69; A61K 31/704; A61K 39/00; A61K 39/395; A61K 45/06; C07K 16/28; C07K 16/30; G01N 33/574; G01N 33/68; A61K 47/68;

Publication

European Patent Bulletin

Issue number:

202003

Publication date:

15/01/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages